title: Decision-making on malaria vaccine introduction: the role of cost-effectiveness analyses.
authors.affiliation: Initiative for Vaccine Research, Department of Immunization, Vaccines & Biologicals, World Health Organization, Geneva, Switzerland. moorthyv@who.int
authors.forename: Vasee S
authors.initials: VS
authors.lastname: Moorthy
authors.forename: Raymond
authors.initials: R
authors.lastname: Hutubessy
authors.forename: Robert D
authors.initials: RD
authors.lastname: Newman
authors.forename: Joachim
authors.initials: J
authors.lastname: Hombach
mesh_terms: D017327:Clinical Trials, Phase IV as Topic; D003362:Cost-Benefit Analysis; D003657:Decision Making; D019353:Endemic Diseases / Q000191:economics / Q000517:prevention & control; D055317:Evidence-Based Practice; D006291:Health Policy; D006801:Humans; D007113:Immunity, Innate; D007223:Infant; D008288:Malaria / Q000191:economics / Q000276:immunology / Q000517:prevention & control*; D017780:Malaria Vaccines / Q000191:economics* / Q000276:immunology; D014614:Vaccines, Synthetic / Q000191:economics* / Q000276:immunology
chemical_list: D017780:Malaria Vaccines; C577001:RTS,S-AS01 vaccine; D014614:Vaccines, Synthetic